RecruitingNot Applicable

Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia

Turkey (Türkiye)50 participantsStarted 2025-06-01

Plain-language summary

This observational study aims to compare the effectiveness of ultrasound-guided erector spinae plane (ESP) block and transcutaneous radiofrequency (RF) treatment in patients with postherpetic neuralgia. Pain intensity and neuropathic pain characteristics will be evaluated using the Visual Analog Scale (VAS) and the Self-Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) score.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Diagnosis of postherpetic neuralgia involving cervical, thoracic, or lumbar regions Age between 18 and 80 years Persistent pain despite conservative treatment Baseline VAS score \> 5 Exclusion Criteria: Ophthalmic or extremity postherpetic neuralgia Allergy to local anesthetics Pregnancy Coagulopathy or use of antiplatelet therapy Cognitive impairment preventing informed consent

What they're measuring

VAS

Timeframe: Baseline, post-procedure 1 month

Trial details

NCT IDNCT07400640

SponsorDiskapi Teaching and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06-01

Contact for this trial

AYSE BETUL ACAR

+905326685180 betulbozann@gmail.com

View on ClinicalTrials.gov More Postherpetic Neuralgia trials